Scheme

ITI Pharma and Healthcare Fund

Holds 37 companies worth ₹264 Cr in Sept 2026.

  • Fund house

    ITIThe fund house that runs this scheme.
  • AUM

    ₹266 CrITI Pharma and Healthcare Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 3.7% on Aug 2026, ₹276 Cr.
  • Largest holding

    Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 12.0% of this scheme's NAV.
  • Fund manager

    Nilay DalalRuns it since 8 May 2026, as the fund house dates it. With Animesh Singh (fund manager).

Overview(7 Oct 2026)

Fund managers2

  1. Nilay DalalFund manager · May 2026 · 14y · MBA
  2. Animesh SinghFund manager · May 2026 · 23y · CFA PGDM
  1. Dhimant ShahDec 2022 – May 2026
  2. Rajesh BhatiaJun 2024 – Apr 2026
  3. Rohan KordeNov 2021 – Apr 2026

Key facts

Benchmark
Nifty Healthcare Total Return Index
Risk
Very High
Expense
Regular 2.59% · Direct 0.89%
Exit load
0.5% within 3 months
Started
8 Nov 2021
Minimum
₹5,000

Source.Its Scheme Summary Document as of 7 Oct 2026 at AMFI.

What changed(11 changes)

Aug 2026

1 change
  1. Expense ratio
    30 AugRegular 2.69% → 2.63%Direct 0.98% → 0.92%

Jul 2026

1 change
  1. Expense ratio
    30 JulRegular 2.66% → 2.69%Direct 0.95% → 0.98%

Jun 2026

1 change
  1. Expense ratio
    29 JunRegular 2.38% → 2.66%Direct 0.68% → 0.95%

Source.Its filings at NSE, since Jul 2025.

Fund managers over time(Nov 2021 – now)

MainCoSlice20222023202420252026
Fig. 1.Who ran it when: each manager from the date the fund house gives, or the first document listing them where it gives none, to when they left. A slice is part of it: overseas, gold and silver, or arbitrage.

Costs(Jul 2025 – Oct 2026)

Every change to the expense ratio, newest first.
7 changesRegularDirectΔ pt
30 Aug 20262.63%0.92%0.06
30 Jul 20262.69%0.98%0.03
29 Jun 20262.66%0.95%0.27
30 May 20262.38%0.68%0
29 Apr 20262.41%0.68%1.22
30 Mar 20263.64%1.90%1.43
31 Jul 20252.35%0.47%–
Direct plan, 30 Aug 2026
0.92%
Regular plan 2.63% · Exit load 0.5% within 3 months
Fig. 1.Total expense ratio a year, each plan's, as its Scheme Summary Documents state it, filing by filing at NSE. A change holds until the next.

Objective and risk(7 Oct 2026)

Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Risk, type and benchmark

Riskometer
Very High
At launch
Very High
Type
An open ended Equity scheme investing in Pharma and Healthcare
Benchmark
Nifty Healthcare Total Return Index

Asset allocation it may hold% of NAV

  1. Equity, Units issued by REITs & Equity related instruments of companies engaged in pharma and healthcare
    Allowed80–100%
  2. Equity, Units issued by REITs and Equity related securities of other Companies
    Allowed0–20%
  3. Listed Preference Shares
    Allowed0–10%Holds99.3%
  4. Debt and Money Market Instruments
    Allowed0–20%Holds0.7%
  5. Units issued by InvITs
    Allowed0–10%Holds0.0%

Holds in Sept 2026.99.3% equity · 0.7% debt and cash

How to invest(7 Oct 2026)

Buying

To start
₹5,000, then in multiples of ₹1
To add
₹1,000, then in multiples of ₹1
Systematic
SIP-Daily/Weekly/Monthly, STP- Daily/Weekly/Monthly/Quarterly, SWP- Monthly/ Quarterly
Dates
SIP-Daily (Every Business Day), Weekly (Any Day from Monday to Friday),Monthly (Every Business Day), STP- Daily (Every Business Day), Weekly (Any Day from Monday to Friday),Quarterly (1st or 7th or 14th or 21st or 28th of last month of every quarter), Monthly (1,7,14,21 or 28th of the month), SWP-Monthly and Quarterly (1,7,14,21 or 28th of every month/month of every quarter)
Minimum
SIP-Daily: Rs. 500/-/ Weekly and Monthly:Rs. 500/- or Rs. 1000/-, STP- Rs. 500/-, SWP- Rs. 1000/-, then sIP-1, STP-1, SWP-1
Instalments
SIP-Daily- 30 ; Weekly/Monthly -12 or 6, STP-Daily-30; Weekly /Monthly/Quarterly-2, SWP- Monthly/Quarterly-2
Most
Nil

Selling and switching

To redeem
₹1,000
Switch minimum
₹5,000
Switch multiples
₹1

Scheme details(7 Oct 2026)

What it is

Category
Sectoral/Thematic Funds
Offer
18 Oct 2021 to 1 Nov 2021
Started
8 Nov 2021
Reopened
11 Nov 2021
Plans
Regular Plan- Growth Option · Regular Plan- Income Distribution cum Capital Withdrawal (IDCW) Option (with Payout of IDCW option) · Regular Plan- Income Distribution cum Capital Withdrawal (IDCW) Option (with Reinvestment of IDCW option) · Direct Plan- Growth Option · Direct Plan- Income Distribution cum Capital Withdrawal (IDCW) Option (with Payout of IDCW option) · Direct Plan- Income Distribution cum Capital Withdrawal (IDCW) Option (with Reinvestment of IDCW option)
Face value
Rs.10/- each
Listed
No

How it is run

Swing pricing
No
Side-pocketing
No
Custodian
Deutsche Bank A.G.
Auditor
S. R. Batliboi & Co. LLP
Registrar
KFin Technologies Limited
SEBI code
ITIM/O/E/SEC/21/09/0014